Celldex Therapeutics (CLDX +1.5%) gets a boost after announcing positive results in its Phase 2...

|About: Celldex Therapeutics, Inc (CLDX)|By:, SA News Editor

Celldex Therapeutics (CLDX +1.5%) gets a boost after announcing positive results in its Phase 2 clinical trials for rindopepimut, a drug treatment for brain cancer patients with newly diagnosed glioblastoma.